Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares MSCI Indonesia ETF (EIDO) vs Nuwellis Inc (NUWE) Price & Performance

iShares MSCI Indonesia ETFTrade
Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

iShares MSCI Indonesia ETF vs Nuwellis Inc — how do they compare? iShares MSCI Indonesia ETF trades at $12.47, while Nuwellis Inc trades at $1.48 (market cap $522.76K). The key difference: iShares MSCI Indonesia ETF is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.

EIDONUWE
52-Week High
$19.22$220.50
52-Week Low
$10.80$1.42
Market Cap
$522.76K
Sector
Technology
Enterprise Value
-$1.29M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares MSCI Indonesia ETF

EIDO, the iShares MSCI Indonesia ETF, trades at $12.91, up 2.38% today, with a bullish technical signal from moving averages but neutral oscillators. The stock shows support and resistance clustered around $13. Recent news highlights Indonesia's economic initiatives, including AI integration in government programs and reforestation plans, while facing challenges from foreign capital outflows and central bank rate hikes to support the rupiah.

The outlook for EIDO is mixed, with low valuation offering potential upside, but weak price action and high financial sector exposure limit gains. Risks include geopolitical volatility and dependence on commodity markets, though government reforms could boost long-term growth. Investors should weigh bargain valuations against macroeconomic headwinds for balanced exposure.

Nuwellis Inc

NUWE trades at $1.49, down 8.59% over the past day, with a bearish technical outlook. The company reported a net loss of $17.52M in 2025, with a negative net income margin of -217.22%, though it has shown revenue growth and recent strategic expansions in pediatric care. A recent 35:1 reverse stock split was executed on June 26, 2026.

The outlook remains high-risk due to persistent losses and cash burn, but growth initiatives and new product development offer potential. Key risks include execution challenges and dependence on financing. Analyst sentiment is mixed, with a 50% buy and 50% hold rating among covered analysts.

Returns comparison

Trailing returns across standard periods

About iShares MSCI Indonesia ETF

The fund generally will invest at least 80% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The index is a free float-adjusted market capitalization-weighted index that is designed to measure the performance of the large-, mid- and small-capitalization segments of the equity market in Indonesia. The fund is non-diversified.

Read more on EIDO

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE